These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26740985)

  • 21. Investigating the steroids and long-acting beta 2-agonists combination: why do we need more?
    Papi A
    Eur Respir J; 2004 Apr; 23(4):501-2. PubMed ID: 15083743
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination therapy for chronic obstructive pulmonary disease: one size fits all?
    Rabe KF
    Eur Respir J; 2003 Dec; 22(6):874-5. PubMed ID: 14680071
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
    MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
    [No Abstract]   [Full Text] [Related]  

  • 24. New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β2 agonists in combination or combined into a single molecule.
    Norman P
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1569-80. PubMed ID: 23962341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
    Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerations for new dual-acting bronchodilator treatments for chronic obstructive pulmonary disease.
    de Miguel-Díez J; Jiménez-García R
    Expert Opin Investig Drugs; 2014 Apr; 23(4):453-6. PubMed ID: 24392807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and novel bronchodilators in respiratory disease.
    Spina D
    Curr Opin Pulm Med; 2014 Jan; 20(1):73-86. PubMed ID: 24247039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple therapy vs. dual bronchodilator therapy for chronic obstructive pulmonary disease: Is it worth the cost?
    Horita N; Kaneko T
    Respir Investig; 2015 Jul; 53(4):173-5. PubMed ID: 26100178
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Busch-Petersen J; Lainé DI
    Future Med Chem; 2011 Oct; 3(13):1623-34. PubMed ID: 21942252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future of chronic obstructive pulmonary disease management.
    D'Urzo A; Vogelmeier C
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.
    Babu KS; Morjaria JB
    Ther Adv Respir Dis; 2015 Apr; 9(2):56-68. PubMed ID: 25754881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological therapy of chronic obstructive pulmonary disease].
    Montuschi P
    Ann Ist Super Sanita; 2003; 39(4):557-72. PubMed ID: 15098576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov; 145(46):47. PubMed ID: 14699834
    [No Abstract]   [Full Text] [Related]  

  • 35. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
    Schultze-Werninghaus G
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():1. PubMed ID: 12593173
    [No Abstract]   [Full Text] [Related]  

  • 36. New options for bronchodilator treatment in COPD.
    Calverley PM
    Thorax; 2010 Jun; 65(6):468-9. PubMed ID: 20522838
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical aspects of anticholinergic agents].
    Friedman M
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
    [No Abstract]   [Full Text] [Related]  

  • 38. The COPD pipeline XXIV.
    Gross NJ
    COPD; 2013 Oct; 10(5):625-7. PubMed ID: 24040908
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bronchodilator therapy of COPD].
    Kirsten AM; Watz H; Magnussen H
    Dtsch Med Wochenschr; 2014 Feb; 139(6):264-7. PubMed ID: 24473845
    [No Abstract]   [Full Text] [Related]  

  • 40. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.